P. M. A. Calverley (Liverpool, United Kingdom), J. A. Hedner (Gothenburg, Sweden)
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) R. Plywaczewski, M. Bednarek, L. Jonczak, P. Bielen, D. Gorecka, P. Sliwinski (Warsaw, Poland)
|   |
Relation between blood gas lactate levels as a tissue hypoxia marker and periodic leg movement of sleep in patients with OSAS and overlap syndrome Z. Sarp Taymaz, Z. Z. Ucar, A. E. Erbaycu, C. Kirakli, P. Cimen, F. Tuksavul, S. Z. Guclu (Izmir, Turkey)
|   |
Influence of electrostimulation of pharyngeal and laryngeal muscles in complex with traditional treatment of COPD on functional signs of obstructive sleep apnea syndrome in patients with combined pathology – obstructive sleep apnea syndrome + COPD Y. Feschenko, L. Yashyna, I. Dzhavad, G. Gumenuk, K. Miheeva (Kiev, Ukraine)
|   |
The measurement of arterial blood gas lactate levels as a marker of tissue hypoxia in OSAS and overlap syndrome Z. Z. Ucar, Z. Sarp Taymaz, A. E. Erbaycu, C. Kirakli, P. Cimen, F. Tuksavul, S. Z. Guclu (Izmir, Turkey)
|   |
Clinical-functional characteristics in patients with combination pathology – chronic obstructive pulmonary disease and obstructive sleep apnea-hypopnea syndrome L. Yashyna, Y. Feschenko, G. Sidun, K. Miheeva (Kiev, Ukraine)
|   |
Effect of smoking on obstructive sleep apnoea (OSA) M. Bednarek, R. Plywaczewski, P. Bielen, P. Sliwinski, D. Gorecka (Warsaw, Poland)
|   |
Values of diffusing capacity for carbon monoxide (DLco) in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease – (overlap syndrome) T. Mondeshki, D. Petrova, O. Geordiev, V. Pencheva (Sofia, Bulgaria)
|   |
Reliability and validity of the COPD and asthma sleep impairment scale D. A. Revicki, D. M. Meads, G. A. Glendenning, S. P. McKenna, R. Flood (Bethesda, MD, United States Of America; Manchester, Horsham, United Kingdom)
|   |
The effects of formoterol/budesonide on sleep quality of COPD patients G. Sagcan, U. Memis, C. Cuhadaroglu, C. Sen, E. Duygu (Istanbul, Turkey)
|   |
High prevalence of central sleep apnea in patients with pulmonary hypertension S. Ulrich, M. Fischler, R. Speich, K. Bloch (Zurich, Switzerland)
|   |
CPAP and uvulopalatopharyngoplasty (UPPP) normalized pulmonary hypertension in patients with obstructive sleep apnea (OSAS) M. Marvisi, E. Bassi, M. Brianti, P. Zambrelli, L. Zanlari, M. Vento, G. Civardi, R. Delsignore (Fiorenzuola d‘Arda, Parma, Italy)
|   |
Occurrence of severe sleep related breathing disorders following acute myocardial infarction R. Staats, O. Matynenko, C. Virchow (Amadora-Sintra, Lisbon, Portugal; Rostock, Germany)
|   |
Myocardial infarction and sleep disordered breathing with airway obstruction B. Hannhart, J. J. Medina, H. Blangy, F. Chabot (Nancy, France)
|   |
Association between severe obstructive sleep apnea syndrome and sinus dysfunction X. Zhang, H. Wang, K. Yin, C. Li (Nanjing, China)
|   |
Nocturnal heart rate entropy is related to daytime blood pressure L. Grote, D. Zou, J. Radlinski, D. Eder, J. Hedner (Gothenburg, Sweden; Rabka, Zdrój, Poland)
|   |
Association between obstructive sleep apnea syndrome and coronary atherosclerostic disease X. Zhang, K. Yin, C. Li (Nanjing, China)
|   |
Impact of beta-blockers on sleep-disoredered breathing in chronic heart failure C. Philippe, E. Vermes, T. Damy, F. Yacoubi, O. Jobard, F. Roudot-Thoroval, L. Hittinger, M. P. D‘Ortho (Paris, Créteil, France)
|  |
Rationale and design of the randomised intervention with CPAP in coronary artery disease and obstructive sleep apnoea – RICCADSA trial Y. Peker, H. Glantz, J. Ejdebäck, A. Kallryd, J. Herlitz (Skövde, Skövde and Lidköping, Gothenburg, Sweden)
|   |
Urine albumin excretion (UAE) is predictive of subclinical cardiovascular diseases associated with obstructive sleep apnea syndrome (OSA) J. L. Pepin, J. Remy, R. Tamisier, J. C. Renversez, N. Arnol, J. P. Baguet, P. Levy (Grenoble, France)
|   |
C-reactive protein (CRP) and prevalence of cardiovascular diseases in obstructive sleep apnoea (OSA) patients R. Plywaczewski, P. Bielen, J. Czerniawska, M. Bednarek, L. Jonczak, D. Gorecka, P. Sliwinski (Warsaw, Poland)
|   |